Drugs with this side effect
- 1,25(OH)2D3
- 17-hydroxyprogesterone: postmarketing
- 2-hydroxysuccinaldehyde: 10.1% - 42%
- 4-methylpyrazole
- 5-ASA: postmarketing, common, 0% - 26%
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 28.4% - 53%
- 5-azacytidine: very common, 0.98% - 51.8%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- 8-MOP: postmarketing
- ACTH(1-39: 5%
- APAs
- Anidulafungin: 0.667% - 18.4%
- BCNU: 17.5%
- BPTI
- Benicar-HCT
- Bivalirudin: 0.5% - 5.02%
- CAS 76095-16-4
- CAS 76420-72-9: postmarketing
- CGP 19835A: very common, 85%
- Cancidas: 1.1% - 69.7%
- Carfilzomib: 0.38% - 30.4%
- Colimycin M
- D-penicillamine
- EDTA
- Enfuvirtide
- Eptifibatide: 1.6%
- FAMP: 60% - 69%
- FK463: 7% - 64.6%
- FdUrd
- Fe(III: postmarketing, 0% - 9%
- Gd-DTPA
- Ge-132: postmarketing, 77% - 90%
- Glat copolymer
- Goserelin
- Hoe 140: 3.9%
- Humalog: 6.17% - 11.6%
- ICI 182,780: 6.4%
- Implanon: postmarketing
- K779: 3% - 94%
- L-Dmp
- LMWH: 0% - 8%
- LY146032: postmarketing, common, 0% - 8.62%
- Leuprorelin
- LiOH
- Lisinopril: postmarketing, 0.3% - 1.1%
- Lovaza
- Lutalyse
- Meropenem anhydrous
- Metrodin: 0% - 4.2%
- N-acetylcysteine
- N-carbamylglutamate: uncommon
- NSC 352122
- NuvaRing
- Octreotide: 0-2%
- Oestrogen
- Optison: rare
- PCI-32765: 1% - 24%
- PGE1
- PGE2
- Photofrin: 0% - 31%
- Photofrin II: common, very common, 20%
- Refludan: 2.5% - 3%
- Revasc
- Romidepsin: 1.2% - 46.8%
- S-benzoylmercaptoacetyltriglycine
- SU5416
- Supremon
- T-A2-3
- TlCl
- Triptorelin
- UDCA: postmarketing
- VACV: 1.4% - 11%
- Vallergan
- Vancocine
- Vitrum: 0.102%
- Zyprexa Relprevv
- abacavir: common, 3.37% - 83%
- abacavir-lamivudine: common
- abiraterone: 0.2% - 0.6%
- acamprosate: infrequent
- acebutolol
- acenocoumarol
- acetaminophen: 1.05% - 5.47%
- acetazolamide
- acitretin: postmarketing
- actinomycin D
- acyclovir: common, 4%
- adefovir dipivoxil
- afatinib: common, 0% - 12%
- albendazole: 0% - 1%
- alendronate: postmarketing
- alfentanil
- allopurinol
- almotriptan: rare
- alprazolam: infrequent
- amantadine: postmarketing
- ambrisentan
- amifostine
- aminoglutethimide
- aminophylline
- amiodarone: postmarketing, 1.27% - 2.95%
- amitriptyline: postmarketing
- ammonia
- amobarbital
- amoxapine
- amphetamine
- amphotericin B: 7% - 91%
- ampicillin
- amsacrine
- anagrelide: 8.9% - 9%
- anastrozole
- anthracycline: 5% - 49%
- aprepitant: 5.9% - 10.6%
- argatroban: 0.5% - 9%
- aripiprazole: 3% - 9%
- arsenic
- arsenic trioxide: common
- atazanavir: postmarketing, uncommon, 18% - 19%
- atenolol: postmarketing
- atomoxetine: postmarketing, 3%
- atorvastatin
- atosiban
- atovaquone: 0% - 40%
- atropine: rare
- avanafil
- azathioprine
- azelastine
- azithromycin: 0% - 4.2%
- aztreonam: 1% - 13%
- baclofen: common, 0.2% - 0.7%
- balsalazide: 0% - 11.4%
- belinostat: 2% - 35%
- bendamustine: 1% - 34%
- benzathine penicillin
- benztropine
- bepridil
- betaxolol
- bexarotene: 4.76% - 17%
- bicalutamide
- bisoprolol: 2.1%
- bleomycin hydrochloride: 50%
- boceprevir: very common, 21%
- bortezomib: 0% - 36.8%
- bosentan
- bosutinib: 23.4% - 26%
- bretylium
- bromcresol green: 0% - 17%
- bromocriptine: postmarketing
- budesonide: postmarketing
- bupivacaine: 0% - 17%
- buprenorphine: 1.08% - 5.52%
- bupropion: postmarketing, frequent, 1% - 2%
- buspirone: infrequent
- busulfan: 80% - 83%
- butabarbital
- butorphanol: infrequent
- cabazitaxel: 1%
- candesartan
- candesartan cilexetil
- capecitabine: 1% - 34%
- captopril: postmarketing
- carbamazepine: very rare, rare
- carbenicillin
- carbimazole
- carboplatin
- carboprost
- carnitine: 5% - 12%
- carvedilol: 2.3% - 3.1%
- cefaclor
- cefadroxil
- cefazolin
- cefdinir: postmarketing
- cefditoren
- cefepime: 1% - 7%
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil
- ceftaroline
- ceftazidime: uncommon
- ceftizoxime
- ceftobiprole
- ceftriaxone
- cefuroxime
- cefuroxime axetil
- celecoxib: 8% - 11%
- cephalexin
- cephem
- cerivastatin
- cetirizine: 4.12% - 4.39%
- cevimeline
- chlorambucil: 1%
- chloramphenicol
- chloride
- chloroprocaine
- chlorpromazine
- cidofovir: postmarketing, 14.1% - 58.3%
- cilostazol
- cimetidine: rare
- cinacalcet: 7%
- ciprofloxacin: postmarketing, uncommon
- cisplatin
- citalopram: uncommon, frequent, 1% - 2.3%
- cladribine: very common, 33% - 69%
- clarithromycin: postmarketing, common, 2.2%
- clindamycin: 1%
- clobazam: 10% - 17%
- clofarabine: very common, 19%
- clofazimine
- clomiphene citrate: postmarketing
- clomipramine: 2% - 4%
- clonazepam
- clonidine: 1% - 5%
- clopidogrel: postmarketing
- clozapine: 4% - 13%
- cobicistat: uncommon
- codeine
- conivaptan: 3.8%
- copolymer 1
- cortisol
- crizotinib
- cyclophosphamide: postmarketing
- cyproterone acetate
- cysteamine: very common, 22% - 28%
- cytarabine: 0% - 45.5%
- dabrafenib: very common, 0% - 71%
- dacarbazine
- dalteparin: 1.54% - 2.1%
- danazol
- dantrolene: postmarketing
- dapsone: 1%
- darunavir
- dasatinib: very common, 0% - 18%
- deferasirox: uncommon
- deferiprone: postmarketing
- deferoxamine: common
- degarelix
- delamanid
- delavirdine
- deprenyl: infrequent
- desflurane: postmarketing
- desipramine
- desloratadine
- desmopressin: 15%
- dexamethasone
- dexamethasone sodium phosphate
- dexmedetomidine: postmarketing, common, 0% - 7%
- dexrazoxane: 18% - 35%
- dextran
- diatrizoate
- diazoxide
- dichlorphenamide
- diclofenac
- dicloxacillin
- didanosine: postmarketing
- diflunisal
- dihydroergotamine: infrequent
- diltiazem: postmarketing
- dimercaptosuccinic acid
- disopyramide
- docetaxel: 0% - 37%
- dolasetron: 2.2% - 4.92%
- donepezil: infrequent, 2%
- dorzolamide
- doxapram
- doxazosin
- doxepin
- doxercalciferol
- doxorubicin: postmarketing, common, 0% - 30.6%
- doxycycline: 1% - 1.9%
- doxycycline hyclate
- droperidol
- duloxetine: 1% - 3%
- ecallantide: 4% - 5%
- efavirenz: 21% - 26%
- eletriptan: rare
- eltrombopag: 14%
- emtricitabine: postmarketing, 18%
- enflurane
- entacapone
- entecavir: 14%
- ephedrine
- eplerenone
- eprosartan
- eribulin: 1% - 21%
- erlotinib
- ertapenem: 2.3% - 8.3%
- eslicarbazepine acetate
- esmolol: 1%
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing
- ethacrynic acid
- ethambutol
- ethotoin
- etodolac
- etoposide: 24%
- etoposide phosphate
- etravirine
- everolimus: common, very common, 0% - 31%
- exemestane: 5%
- ezetimibe
- famciclovir: 1.1%
- famotidine
- febuxostat
- felbamate: 2.6% - 22.6%
- felodipine
- fenofibrate
- fenoldopam
- fenoprofen: postmarketing
- fentanyl: very rare, postmarketing, common, 4.92% - 35%
- ferumoxytol: postmarketing, 0.7% - 1%
- fexofenadine: 1.9% - 4.5%
- flecainide
- flucloxacillin
- fluconazole: postmarketing, uncommon
- fludarabine: 11% - 69%
- flunisolide: 0.9% - 6.9%
- fluocinolone acetonide
- fluoxetine: infrequent, 2% - 3%
- fluphenazine
- fluphenazine decanoate
- flurbiprofen
- fluticasone: 1% - 7%
- fluticasone furoate: 4.46% - 4.61%
- fluticasone propionate
- fluvastatin: postmarketing
- fluvoxamine: postmarketing, rare, infrequent
- fondaparinux: uncommon, 0.3% - 15.4%
- formoterol: 2.2%
- fosamprenavir
- fosaprepitant dimeglumine: 5.9% - 10.6%
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: uncommon
- fosinoprilat
- fosphenytoin: frequent
- fotemustine: common
- frovatriptan: infrequent
- furosemide
- gabapentin: postmarketing, rare, infrequent, 1.3% - 10.1%
- gadobenate dimeglumine: 2.7%
- gadobutrol
- gadodiamide
- gadofosveset
- gadolinium: postmarketing, 0.9%
- gadopentetate
- gadoteridol: 0.08%
- gadoversetamide
- galantamine: frequent
- ganciclovir: 9% - 35.9%
- gatifloxacin
- gefitinib: common
- gemcitabine: common, very common, 0% - 41%
- gemeprost
- gemifloxacin: postmarketing
- gentamicin
- gliclazide
- glucose
- glucose solution
- glutamine: 0% - 22.2%
- glycopyrrolate
- gold sodium thiomalate
- granisetron: 3% - 7.9%
- guanidinium
- haloperidol: very rare, postmarketing
- hemin
- heparin: postmarketing
- hepatitis B vaccines: common
- hetastarch: postmarketing
- histamine
- homatropine
- hydralazine: uncommon
- hydrochlorothiazide
- hydrocodone
- hydromorphone: 2.1%
- hydroxocobalamin
- hydroxychloroquine
- hydroxyl radicals
- hydroxyurea
- ibandronate
- icodextrin: postmarketing
- idarubicin: 26% - 28%
- ifosfamide: postmarketing, 1% - 8%
- iloperidone
- imatinib: common, 0% - 42.6%
- imipramine: very rare
- imiquimod: uncommon, 0% - 3.12%
- indapamide: postmarketing
- indinavir: 1.5% - 2.1%
- indomethacin
- insulin detemir: 1.2% - 10.3%
- iodide
- iodipamide
- iodixanol
- iohexol
- iopamidol
- iopromide
- iotrolan
- ioversol: 1.3% - 1.6%
- ioxaglate
- ioxilan
- irbesartan
- irbesartan-hydrochlorothiazide
- irinotecan: 0.4% - 45.4%
- iron sucrose
- isoflurane
- isomannide
- isoniazid
- isosorbide-5-mononitrate
- itraconazole: postmarketing, 0% - 8%
- ivermectin: 7% - 22.6%
- ixabepilone: 0% - 8%
- ketoconazole
- ketorolac
- ketorolac tromethamine: postmarketing
- ketotifen
- labetalol
- lacosamide
- lamivudine: common, 6% - 32%
- lamotrigine: 0% - 15%
- lansoprazole
- lasofoxifene: rare
- leflunomide
- lenalidomide: postmarketing, very common, 2.24% - 27.5%
- lercanidipine
- letrozole: uncommon
- leucovorin
- leuprorelin acetate: 5.63% - 11.3%
- levetiracetam: 1.3%
- levonorgestrel
- lincomycin
- linezolid: 0% - 14.1%
- lisdexamfetamine dimesylate: 2%
- lithium
- lithium carbonate
- lomitapide
- lomustine
- loratadine
- losartan: 4%
- lovastatin: postmarketing
- mTHPC: common
- mannitol
- maprotiline
- maraviroc: 9% - 13%
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 1% - 6%
- meloxicam
- memantine
- mepivacaine
- meprobamate
- meropenem: 0.2%
- mesna
- metaproterenol: 0.4% - 2%
- methadone
- methazolamide
- methocarbamol
- methotrexate
- methyclothiazide
- methyldopa
- methylene blue
- methylene diphosphonate
- methylphenidate: postmarketing, common, 2.2%
- methysergide
- metoclopramide
- metoprolol
- metronidazole
- mexiletine: 1.2% - 3.1%
- mifepristone
- milnacipran
- mipomersen: 8%
- mirtazapine: postmarketing, infrequent
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone: 18% - 78%
- modafinil: 1%
- mometasone: 7%
- monoethanolamine: 1.8%
- montelukast: postmarketing, 1.5%
- morphine: 2%
- moxifloxacin: 0.4%
- mycophenolate mofetil: 1% - 56.1%
- mycophenolic acid: 12.7% - 56.1%
- nabilone
- nabumetone: postmarketing, 0.4%
- nadolol
- nafcillin
- nalbuphine
- nalmefene: 3% - 4%
- naloxone
- naltrexone
- naproxen: postmarketing, 1% - 1-3%
- naratriptan: infrequent
- nedocromil sodium
- nefazodone
- nelarabine: 0% - 23%
- nelfinavir: postmarketing, 0% - 2.56%
- nevirapine: postmarketing, uncommon, common, 1% - 2%
- niacin
- nicardipine
- nicorandil: uncommon
- nicotine
- nifedipine
- nilotinib: common
- nilutamide
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nitroglycerin
- nizatidine: postmarketing, 1.6%
- norfloxacin: postmarketing
- nortriptyline
- ofatumumab: 3% - 25%
- ofloxacin: postmarketing, 0.3%
- olanzapine: rare, infrequent, common, 0% - 6%
- olmesartan: 0% - 3.23%
- olodaterol
- olopatadine: 1.01% - 1.34%
- olsalazine: postmarketing
- omeprazole: postmarketing, rare, 3.47%
- ondansetron: 1.83% - 8.18%
- orlistat
- oseltamivir: postmarketing
- oxacillin
- oxaliplatin: very common, 0% - 36%
- oxaprozin
- oxazepam
- oxcarbazepine: very rare, postmarketing, 0% - 3%
- oxycodone
- oxymorphone: 14%
- paclitaxel: postmarketing, rare, very common, 1% - 14%
- paliperidone
- palonosetron
- pamidronate: postmarketing, very common, 0% - 38.5%
- pantoprazole: very rare, postmarketing, rare
- paricalcitol: 4.8%
- paroxetine: rare, infrequent, common
- pemetrexed: 0% - 26%
- pemirolast
- penbutolol
- penicillin
- penicillin V
- pentamidine: 51%
- pentobarbital
- pentostatin: 42% - 59%
- pentoxifylline
- pergolide: frequent
- perindopril: 0.3% - 1.5%
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- permethrin
- perphenazine
- phenelzine
- phenobarbital
- phenytoin: frequent
- pilocarpine
- pimecrolimus: 1.2% - 12.5%
- piperacillin: uncommon
- piroxicam
- pixantrone
- polymyxin B
- pomalidomide: 2.8% - 30.4%
- ponatinib: 0% - 32%
- posaconazole: 6.1% - 34.3%
- potassium
- pralatrexate
- pramipexole: 1%
- prasugrel: 2.2% - 2.7%
- pravastatin: 2.1%
- praziquantel
- prazosin
- prednisolone phosphate
- prednisone
- pregabalin: rare, frequent
- probenecid
- procainamide
- procaine
- procaine penicillin
- procarbazine
- prochlorperazine
- progesterone
- proguanil
- propafenone: 1.9% - 10%
- propericiazine
- propofol
- propranolol: postmarketing
- propylthiouracil
- prostacyclin: 11% - 25%
- prostaglandin: 1.18% - 1.36%
- prucalopride: uncommon
- pyrazinamide
- quetiapine: 1% - 4%
- quinidine: 5%
- rabeprazole
- raloxifene: 3.1% - 3.9%
- raltegravir: 4.9%
- raltitrexed: 20%
- ramipril
- ramiprilat
- ranitidine
- rapamycin: 19% - 35%
- rasagiline: common, 3%
- rasburicase: 0% - 46%
- reboxetine
- regorafenib
- remifentanil: 0% - 13.2%
- retapamulin: 1% - 1.2%
- retinoic acid: 83%
- ribavirin: very common, 4% - 80%
- rifabutin: 2%
- rifampicin
- rifapentine
- rifaximin: 3.12% - 6.43%
- riluzole
- risedronate: 0.8% - 2%
- risperidone: 0% - 20%
- ritonavir: 0.9% - 5%
- rivastigmine: frequent
- rizatriptan: rare
- rofecoxib
- ropinirole: infrequent, frequent
- ropivacaine: 0.8% - 20.7%
- ruxolitinib
- salbutamol: postmarketing, 1.6% - 9.1%
- salmeterol
- salmon calcitonin acetate: uncommon
- samarium: 8.54%
- saquinavir
- scopolamine
- secobarbital
- sertraline: postmarketing, infrequent, common
- sevelamer hydrochloride: 5.1% - 10.9%
- sevoflurane: postmarketing
- sibutramine
- sildenafil: 3% - 17%
- simvastatin: postmarketing
- sitaxsentan
- sodium
- sodium acetate
- sodium cromoglycate: 1.6%
- sodium ferric gluconate: 5% - 9%
- sodium iothalamate
- sofosbuvir: common, very common, 0% - 18%
- sorafenib: postmarketing, very common
- sotalol: postmarketing, 1% - 4%
- sparfloxacin
- spectinomycin
- spironolactone
- stavudine: postmarketing
- streptomycin
- streptozotocin: 1%
- strontium
- strontium ranelate: postmarketing
- succinylcholine
- sufentanil: 1%
- sugammadex
- sulfasalazine: 5%
- sulindac
- sumatriptan: rare, infrequent
- sunitinib
- tacrolimus: 1% - 56%
- tamsulosin: 1%
- technetium-99m
- telavancin: uncommon
- telmisartan
- temozolomide: common, 1% - 13.3%
- temsirolimus
- teniposide: 3%
- tenofovir: 2% - 11%
- tenofovir disoproxil fumarate: 2% - 11%
- terazosin: 0.5%
- terbinafine: postmarketing, 6% - 7%
- terconazole: postmarketing, 1.75%
- tetrabenazine
- tetracycline
- tetrahydrobiopterin: 6.76%
- tetrofosmin: postmarketing
- thalidomide: 0% - 23.5%
- theophylline
- thiazide
- thioridazine: postmarketing
- thiotepa: 1-10%
- thymidine: 1% - 4.01%
- thyroxine
- tiagabine
- ticagrelor
- ticlopidine
- tigecycline: 7.1% - 9.8%
- timolol: postmarketing
- tinidazole
- tiopronin
- tipranavir: uncommon, 5.4% - 6.4%
- tirofiban: 1.5%
- tizanidine: frequent
- tobramycin: very common, 12.4% - 32.9%
- tofacitinib
- tolcapone: 0%
- tolmetin
- tolvaptan: common, 4.04%
- topiramate: very rare, postmarketing, frequent, 0% - 12%
- topotecan: very common, 0% - 43%
- trabectedin
- tramadol: postmarketing, uncommon
- trametinib: 0% - 71%
- trandolapril: postmarketing
- trandolaprilat: postmarketing
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- trazodone
- treprostinil
- triamcinolone: 7.9%
- triamcinolone acetonide: 4.47% - 7.69%
- trifluoperazine
- triiodothyronine
- trimethoprim
- trimethoprim-sulfamethoxazole: very rare
- trimetrexate: 1.83% - 12.6%
- trimipramine
- tris
- troglitazone: postmarketing
- trovafloxacin
- v 1784: postmarketing, uncommon, common, 0% - 4%
- valdecoxib
- valganciclovir: 3.85% - 31%
- valproate: common, 1% - 14%
- valrubicin
- vandetanib: 0.9%
- varenicline: infrequent, uncommon
- vemurafenib: postmarketing, 1% - 19%
- venlafaxine: frequent
- verteporfin: uncommon
- vigabatrin: postmarketing, 4% - 29%
- vincristine: 13.3% - 43%
- vinflunine
- vinorelbine: 0% - 4%
- voriconazole: very common, 0% - 13.5%
- vorinostat
- warfarin
- zafirlukast: 1.6%
- zalcitabine
- zaleplon: frequent
- zanamivir: 5% - 9%
- ziconotide: 5%
- zidovudine: uncommon, 2.13% - 32%
- zidovudine/lamivudine
- zileuton
- ziprasidone: rare, frequent
- zoledronic acid: postmarketing, common, very common, 0.3% - 38%
- zolmitriptan: rare, infrequent
- zolpidem: infrequent, 1%
- zonisamide
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|